Sign in
Back
Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy
Journal article   Open access  Peer reviewed

Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy

Daniel S. O'Neil, Sarah Nietz, Ines Buccimazza, Urishka Singh, Sharon Čačala, Laura W. Stopforth, Maureen Joffe, Judith S. Jacobson, Alfred I. Neugut, Katherine D. Crew, …
The oncologist (Dayton, Ohio), Vol.24(7), pp.933-944
2018-12-05
DOI: https://doi.org/10.1634/theoncologist.2018-0535
PMCID: PMC6656461
PMID: 30518615

Abstract

Breast cancer Global Health and Cancer Neoadjuvant chemotherapy Practice patterns South Africa
In sub‐Saharan Africa, clinical decisions can be affected by resource constraints. This article analyzes the clinical and sociodemographic factors associated with receiving neoadjuvant chemotherapy among patients from a previously existing cohort: women enrolled in the prospective South African Breast Cancer and HIV Outcomes study.
url
https://doi.org/10.1634/theoncologist.2018-0535View
Published (Version of record) Open

Metrics

1 Record Views
11 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.119 Breast Cancer Scanning
1.119.454 Breast Cancer Incidence
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Details